COVID-19 Updates
From the Journals
Prioritize COVID-19 vaccination in both types of diabetes, say docs
The study is the first to prospectively evaluate COVID-19 severity factors and death in people with type 1 and type 2 diabetes separately.
Feature
Demand for COVID vaccines expected to get heated – and fast
Experts in ethics and immunization behavior say they expect attitudes to shift quickly from widespread hesitancy to urgent, even heated demand.
Case Reports
Herpes Zoster May Be a Marker for COVID-19 Infection During Pregnancy
A number of cutaneous skin manifestations have appeared in relation to the newly diagnosed coronavirus disease 2019 (COVID-19) pandemic and...
Commentary
Dermatology Battles COVID-19 With Comfort
What can dermatologists, as highly skilled health care experts, do to support the fight against coronavirus disease 2019 (COVID-19)?
Case Reports
Skin Eruption and Gastrointestinal Symptoms as Presentation of COVID-19
The authors present a 52-year-old patient with an ill-defined skin eruption that preceded mild gastrointestinal (GI) symptoms and without...
Commentary
Dermatology and Vaccines: We Must Do Better
Physicians must take the time and effort to promote vaccinations—the health of patients and the general public depends on it.
From the Journals
Infant’s COVID-19–related myocardial injury reversed
Children hospitalized for COVID-19 should be tested for heart failure based on a case report of an infant with COVID-19 and reversible myocardial...
From the Journals
Obesity, hypoxia predict severity in children with COVID-19
Race, ethnicity, and socioeconomic status were not significant predictors of serious illness.
From the Journals
Diabetic retinopathy may predict greater risk of COVID-19 severity
“Our study reports the first description of diabetic retinopathy as a potential risk factor for poor COVID-19 outcomes,” said the authors of a new...
Feature
COVID-19 vaccine distribution could start in 2 weeks, Pence says
The FDA is scheduled to make a decision about Pfizer’s emergency-use authorization after an advisory panel meets on Dec. 10.
News
CDC shortens COVID-19 quarantine time to 10 or 7 days, with conditions
The residual risk is approximately 1%, with an upper limit of 10%, when people quarantine for 10 days. .